Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which diffusion property of substances is analyzed, can be used in diagnosing of coronary vascular diseases
News | Cardiovascular Clinical Studies
Scientists Suggest a New Method for Diagnosing Heart Diseases

May 10, 2024 — Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which ...

Home May 10, 2024
Home
A, Normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with BM = 43.2. B, Fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in 52-year-old woman with BMI = 45.8.
News | Cardiac Imaging
Enlarged Lymph Nodes on Screening Mammograms Predict Cardiometabolic Disease, Cardiovascular Risk

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Home May 10, 2024
Home
The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).
News | ACC
American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines

May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new ...

Home May 09, 2024
Home
The US Food and Drug Administration is alerting health care providers and facilities about our continued safety and quality concerns with the following Getinge/Maquet cardiovascular medical devices
News | FDA
FDA Notes Safety and Quality Concerns with Getinge/Maquet Cardiovascular Devices

May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...

Home May 08, 2024
Home
63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
News | Peripheral Artery Disease (PAD)
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
AltaValve
News | FDA
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies

May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally ...

Home May 08, 2024
Home
Feinstein Institutes’ Dr. Stavros Zanos is the senior author on the new bioelectronic medicine ultrasound paper
News | Hypertension
Ultrasound Neuromodulation Shows Promise to Treat Pulmonary Hypertension, Feinstein Institutes Research

May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...

Home May 08, 2024
Home
AngioFlow by RapidAI will facilitate confident clinical decision-making immediately prior to or after neuro-interventional procedures
News | FDA
RapidAI Secures FDA Clearance for Perfusion Imaging in the Angiography Suite

May 7, 2024 — RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology ...

Home May 07, 2024
Home
‘Scattered Denial’ documents how long-term exposure to radiation in catheterization labs may cause cancer
News | Radiation Dose Management
Documentary Led by HonorHealth Research Institute Focuses on Injuries to Doctors and Nurses Working in Cardiology

May 7, 2024 — HonorHealth Research Institute’s David G. Rizik, M.D., narrates and is a co-producer of a documentary ...

Home May 07, 2024
Home
Medtronic released clinical outcomes in two transcatheter valve therapies from studies presented at the recent Society for Cardiovascular Angiography & Interventions 2024 Scientific Sessions, SCAI 2024.
News | SCAI
Medtronic TAVR Outcomes from SMART Trial and Optimize PRO Addendum on Evolut TAVR Presented at SCAI 2024 Scientific Sessions

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

Home May 07, 2024
Home
An example of white matter hyperintensities (WMHs) on a FLAIR MRI scan in an older adult. FLAIR MRI is a technique that is particularly good at detecting fluid in the brain
News | Stroke
New Study Reveals Age-related Brain Changes Influence Recovery After Stroke

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...

Home May 07, 2024
Home
Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results were presented by lead study author Sahil A. Parikh, MD, Director of Endovascular Services and Professor at Columbia University Irving Medical Center, at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
News | SCAI
Women and Black Patients Less Likely to Receive Catheter-based Treatment for Pulmonary Embolism According to REAL-PE Analysis Presented at SCAI 2024

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...

Home May 07, 2024
Home
HeartX's portfolio includes advanced products like the JOVE VB Stent for Sinus Venous ASD
News | Cardiovascular Business
SMT and HeartX Forge Transformative Partnership in Cardiovascular Space

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire
News | Guidewires
Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire

May 6, 2024 — Teleflex Incorporate, a leading global provider of medical technologies, today announced that the Wattson ...

Home May 06, 2024
Home
Represents the third patent granted to Tenax since March of 2023 protecting the use of levosimendan in the treatment of PH-HFpEF
News | Pharmaceuticals
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

Home May 06, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now